Excise duty exemption on specified pharmaceutical goods reduces effective levy rates for listed formulations and medicaments under defined conditions. Notification exempts specified Chapter 30 pharmaceutical goods from excise duty in excess of amounts calculated at lower effective rates set in the Table, granting nil duty for listed formulations based on bulk drugs and certain named drugs, reduced ad valorem rates for other medicaments and specified surgical products, subject to conditions such as packaging limits, and defines bulk drugs, formulations and brand name for determining scope and eligibility.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Excise duty exemption on specified pharmaceutical goods reduces effective levy rates for listed formulations and medicaments under defined conditions.
Notification exempts specified Chapter 30 pharmaceutical goods from excise duty in excess of amounts calculated at lower effective rates set in the Table, granting nil duty for listed formulations based on bulk drugs and certain named drugs, reduced ad valorem rates for other medicaments and specified surgical products, subject to conditions such as packaging limits, and defines bulk drugs, formulations and brand name for determining scope and eligibility.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
